OpportunityTitle: Integrated Preclinical/Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP-MBP) (U19)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: The purpose of this Funding Opportunity Announcement is to solicit applications from single institutions and consortia of institutions to participate in the Integrated Preclinical Clinical Program for HIV Topical Microbicides and Biomedical Prevention (IPCP-MBP).The objective of each IPCP-MBP application is to create an integrated and iterative multi-disciplinary application with the goal of developing a microbicide, PreExposure Prophylaxis (PrEP), or Multipurpose Prevention Technology (MPT) non-vaccine biomedical prevention (nBP) product or strategy, for use in the male and/or female genital and gastrointestinal (GI) tracts to prevent HIV acquisition/transmission. Products and strategies may be delivered by a variety of drug delivery systems (DDS), including gels, films, quick dissolving tablets, intravaginal rings (IVR), implants, oral, and/or injection. This FOA contains significant modifications to previous iterations of the Integrated Preclinical Clinical Program FOA.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;